medmix AG Statistics

Total Valuation

medmix AG has a market cap or net worth of CHF 401.38 million. The enterprise value is 622.78 million.

Market Cap	401.38M
Enterprise Value	622.78M

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	Apr 25, 2025

Share Statistics

medmix AG has 40.79 million shares outstanding. The number of shares has increased by 0.50% in one year.

Current Share Class	n/a
Shares Outstanding	40.79M
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	-8.88%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	27.26%
Float	23.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.15
PS Ratio	0.83
PB Ratio	0.92
P/TBV Ratio	8.34
P/FCF Ratio	8.34
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.08, with an EV/FCF ratio of 12.95.

EV / Earnings	-84.16
EV / Sales	1.29
EV / EBITDA	9.08
EV / EBIT	46.13
EV / FCF	12.95

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.74.

Current Ratio	1.60
Quick Ratio	1.04
Debt / Equity	0.74
Debt / EBITDA	4.43
Debt / FCF	6.84
Interest Coverage	1.59

Financial Efficiency

Return on equity (ROE) is -1.39% and return on invested capital (ROIC) is 1.50%.

Return on Equity (ROE)	-1.39%
Return on Assets (ROA)	1.22%
Return on Invested Capital (ROIC)	1.50%
Return on Capital Employed (ROCE)	2.43%
Revenue Per Employee	180,291
Profits Per Employee	-2,757
Employee Count	2,684
Asset Turnover	0.49
Inventory Turnover	3.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.01% in the last 52 weeks. The beta is 0.95, so medmix AG's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-42.01%
50-Day Moving Average	11.68
200-Day Moving Average	10.88
Relative Strength Index (RSI)	28.03
Average Volume (20 Days)	47,729

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, medmix AG had revenue of CHF 483.90 million and -7.40 million in losses. Loss per share was -0.18.

Revenue	483.90M
Gross Profit	159.70M
Operating Income	19.20M
Pretax Income	-6.40M
Net Income	-7.40M
EBITDA	64.00M
EBIT	19.20M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 118.10 million in cash and 329.20 million in debt, giving a net cash position of -211.10 million or -5.18 per share.

Cash & Cash Equivalents	118.10M
Total Debt	329.20M
Net Cash	-211.10M
Net Cash Per Share	-5.18
Equity (Book Value)	446.70M
Book Value Per Share	10.70
Working Capital	98.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 86.60 million and capital expenditures -38.50 million, giving a free cash flow of 48.10 million.

Operating Cash Flow	86.60M
Capital Expenditures	-38.50M
Free Cash Flow	48.10M
FCF Per Share	1.18

Full Cash Flow Statement

Margins

Gross margin is 33.00%, with operating and profit margins of 3.97% and -1.53%.

Gross Margin	33.00%
Operating Margin	3.97%
Pretax Margin	-1.32%
Profit Margin	-1.53%
EBITDA Margin	13.23%
EBIT Margin	3.97%
FCF Margin	9.94%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 5.08%.

Dividend Per Share	0.50
Dividend Yield	5.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	4.58%
Earnings Yield	-1.84%
FCF Yield	11.98%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

medmix AG has an Altman Z-Score of 2.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	n/a